The rapid development of novel gene therapies is anticipated to openup new avenues for the Spinal Muscular Atrophy Market
by The Spinal Muscular Atrophy Market is estimated to be valued at US$ 1813.48 Mn or Mn in 2023 and is expected to exhibit a CAGR …